Disability Evaluation, Leprosy, Quality of Life
Conditions
Keywords
Leprosy, Disability Evaluation, Quality of Life, Sensation
Brief summary
Leprosy is an infectious disease of slow evolution, manifested primarily by signs and symptoms dermatoneurological with skin lesions and peripheral nerve, especially in the eyes, hands and feet. The prevention of disability is essential for the control of complications. Objective: To evaluate the physical and functional status of hands, feet and eyes, for the appearance and evolution of sensory and motor deficiencies and classification of disability (WHO) of a group of leprosy patients to compare and monitor the result treatment on the progression of neuropathy and recurrence of reactions. Methodology: We performed initial physical therapy evaluation and final, after 12 months. We conducted a clinical trial of a series of 26 cases evaluated with newly diagnosed leprosy, treated by standard medication. There were used methods of qualitative and quantitative. An illustrated manual of guidelines was especially developed for this study.
Detailed description
assessment methods of qualitative and quantitative: inspection of eyes, hands and foot, manual motor function, grip and pinch dynamometry,threshold test, SF 36 quality of life questionnaire. Intervention: illustrated guidelines, exercises, orthoses, orientation Goals: disability prevention
Interventions
OTHERexercise and orientation
guidances for prevention of disability in leprosy with focus on hands, eyes and feet.
Sponsors
Conselho Nacional de Desenvolvimento Científico e Tecnológico
University of Sao Paulo
Study design
Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* The patients in this project were diagnosed and referred by the dermatology to do the physical-functional evaluation and physiotherapy. We selected patients aged 18 years and both sexes, even with comorbidities, since diagnosed and treated. In accepting to participate in the research, signed a consent form
Exclusion criteria
* Those patients who refused to sign the consent form and those who did not attend the evaluations
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| classification of disability for Leprosy(WHO) | 1 year |
Secondary
| Measure | Time frame |
|---|---|
| classification of disability for Leprosy(WHO), grip strength and threshold sensibility | after 1 year |
Countries
Brazil
Outcome results
None listed